Although it’s an off year for state legislatures, states are expected to make progress on legislation and initiatives to lower drug prices, and state attorneys general are showing more interest in protecting residents from high drug prices, according to National Academy for State Health Policy Executive Director Trish Riley. The policies to watch include drug imports, bulk purchasing, insulin spending caps and drug price review boards. Drug Imports The Trump administration proposed a rule last month to let states...